Overview
Rivia, a Zurich-based software development company specializing in AI-driven clinical trial data infrastructure, has raised an oversubscribed $15 million in a Series A funding round. The round was led by Earlybird Venture Capital, with participation from Defiant and continued support from Speedinvest, Amino Collective, and Nina Capital. This funding will help Rivia enhance its data engine aimed at improving clinical trial intelligence.
Products
Loading...
Recent Deals
Investors: Earlybird Venture Capital, Defiant, Speedinvest, Amino Collective, Nina Capital
Rivia, a Zurich-based software development company specializing in AI-driven clinical trial data infrastructure, has raised an oversubscribed $15 million in a Series A funding round. The round was led by Earlybird Venture Capital, with participation from Defiant and continued support from Speedinvest, Amino Collective, and Nina Capital. This funding will help Rivia enhance its data engine aimed at improving clinical trial intelligence.